ASCO: Studies pave the way on immunotherapy clinical trials for...
Several MD Anderson-led studies at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting focus on using immunotherapy...
Study shows naproxen promotes immune activation in Lynch...
A Phase I chemoprevention clinical trial led by MD Anderson researchers found that naproxen, an over-the-counter anti-inflammatory...
Scientific communication predicts research career intention
“Trainees at the Ph.D. and postdoctoral level are leaving the academic research track at alarming rates, and disproportionately if...
Extending cervical cancer prevention around the world
While U.S. cervical cancer rates have fallen by 70% since the 1950s thanks to the Pap test and national screening programs, the...
E-cigarettes: Unstandardized, under-regulated,...
The recent outbreak of lung injury and death associated with e-cigarettes and vaping has led to a renewed scrutiny of electronic...
Multiple studies show major lack of public knowledge about...
Despite the fact that the human papillomavirus (HPV) vaccine has been available in the U.S. for over 10 years and remains the only...
Studies show early success for pre-surgical immunotherapy...
Early results from two MD Anderson studies show promising responses to neoadjuvant (pre-surgical) checkpoint inhibitors in patients...
Predicting head and neck cancer treatment toxicities with...
MD Anderson researchers have developed the first machine learning algorithm to predict acute toxicities in patients receiving...
Research finds evidence HPV vaccine is improving herd...
A study from researchers at The University of Texas MD Anderson Cancer Center found that the prevalence of the types of oral human...